China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…
Read More »clinical trials
Chongqing, a key economic hub in southwest China, has unveiled a plan to support the development of innovative drugs as…
Read More »Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »

